To date, adalimumab (ADA) is the only biotechnology drug approved for the management of
hidradenitis suppurativa (HS), an inflammatory skin condition. However, it quickly became …

Mucus is an integral part of the respiratory physiology. It protects the respiratory tract by
acting as a physical barrier against inhaled particles and microbes. Excessive inflammation …

Secukinumab is an anti-interleukin (IL)-17A IgG1-κ monoclonal antibody approved for
psoriasis, psoriatic arthritis, and ankylosing spondylitis. Its efficacy is well documented, but …

Secukinumab is an anti-IL-17 monoclonal antibody approved for treating psoriasis and
various arthritides. A comprehensive evaluation of its safety, especially in a real-world …

Objective This study aimed to investigate the clinical features of biologics-induced bullous
pemphigoid (BP) and the therapeutic effects of those agents for BP, exploring the underlying …

Pityriasis rubra pilaris represents a group of familial and acquired disorders of cornification
that affect both adult and pediatric patients. Treatment options are difficult to assess through …

The dysfunctionality of the protective skin barrier in psoriasis allows easier cutaneous
penetration of various contact haptens; thus, such patients can develop allergic contact …

Sarcoidosis is a multisystem disorder of unknown etiology characterized by accumulation of
granulomas in affected tissue. Cutaneous manifestations are among the most common …

Background Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease
associated with a significant negative impact on the quality of life of patients. Methods We …

Behçet's disease is a systemic inflammatory disorder of unknown etiology. The disease
manifests with diverse clinical symptoms, most commonly recurrent oral and genital ulcers …